Published in Europace on October 18, 2012
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA (2007) 3.32
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy. Am J Cardiol (2009) 2.15
Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol (2008) 2.07
Interventricular delay interval optimization in cardiac resynchronization therapy guided by echocardiography versus guided by electrocardiographic QRS interval width. Am J Cardiol (2008) 1.99
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. Int J Cardiol (2005) 1.97
Serial versus isolated assessment of clinical and instrumental parameters in heart failure: prognostic and therapeutic implications. Am Heart J (2003) 1.93
Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. J Am Coll Cardiol (2005) 1.90
First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead. Europace (2011) 1.70
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation. Heart Vessels (2009) 1.66
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol (2013) 1.65
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Rev Esp Cardiol (Engl Ed) (2014) 1.61
Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol (2005) 1.56
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. Pacing Clin Electrophysiol (2010) 1.50
A prospective randomized evaluation of VV delay optimization in CRT-D recipients: echocardiographic observations from the RHYTHM II ICD study. Pacing Clin Electrophysiol (2009) 1.48
Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients. Eur Heart J (2004) 1.46
Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol (2007) 1.44
Longitudinal mechanics of the periinfarct zone and ventricular tachycardia inducibility in patients with chronic ischemic cardiomyopathy. Am Heart J (2010) 1.43
Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device. J Cardiovasc Electrophysiol (2005) 1.42
Prediction of atrial fibrillation in patients with an implantable cardioverter-defibrillator and heart failure. Eur J Heart Fail (2010) 1.40
Uneventful right ventricular perforation with displacement of a pacing lead into the left thorax. J Cardiothorac Vasc Anesth (2008) 1.38
Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation (2010) 1.31
Phrenic stimulation: a challenge for cardiac resynchronization therapy. Circ Arrhythm Electrophysiol (2009) 1.26
Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block. Pacing Clin Electrophysiol (2006) 1.24
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace (2013) 1.16
Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry. J Am Coll Cardiol (2008) 1.07
Response to the letter from dr bertini. Europace (2012) 1.07
Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: a long-term longitudinal study. Stroke (2003) 1.05
108th ENMC International Workshop, 3rd Workshop of the MYO-CLUSTER project: EUROMEN, 7th International Emery-Dreifuss Muscular Dystrophy (EDMD) Workshop, 13-15 September 2002, Naarden, The Netherlands. Neuromuscul Disord (2003) 1.04
Electromechanical effects of cardiac resynchronization therapy during rest and stress in patients with heart failure. Eur J Heart Fail (2007) 1.03
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I. Eur J Cardiovasc Prev Rehabil (2010) 1.03
Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. J Am Coll Cardiol (2011) 1.01
VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3. J Leukoc Biol (2006) 1.00
Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace (2008) 1.00
Left ventricular lead stabilization to retain cardiac resynchronization therapy at long term: when is it advisable? Europace (2013) 1.00
Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database. Circulation (2011) 0.99
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. Pharmacol Ther (2009) 0.98
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II. Eur J Cardiovasc Prev Rehabil (2010) 0.97
The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring. J Med Internet Res (2013) 0.95
Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management. Europace (2010) 0.94
How to truly value implantable cardioverter-defibrillators technology: up-front cost or daily cost? Int J Technol Assess Health Care (2011) 0.94
Role of ventricular Autocapture function in increasing longevity of DDDR pacemakers: a prospective study. Europace (2006) 0.94
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. Echocardiography (2007) 0.94
Calcitriol derivatives with two different side chains at C-20 III. An epimeric pair of the gemini family with unprecedented antiproliferative effects on tumor cells and renin mRNA expression inhibition. J Steroid Biochem Mol Biol (2007) 0.93
Prevention of infections in cardiovascular implantable electronic devices beyond the antibiotic agent. J Cardiovasc Med (Hagerstown) (2014) 0.92
Cardiac resynchronization therapy during rest and exercise: comparison of two optimization methods. Europace (2008) 0.91
Comparison of two strategies to reduce ventricular pacing in pacemaker patients. Pacing Clin Electrophysiol (2008) 0.90
Meta-analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: effect on all-cause mortality and hospitalizations. Eur J Heart Fail (2012) 0.90
Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy. Eur J Heart Fail (2011) 0.90
Electrical storm in patients with biventricular implantable cardioverter defibrillator: incidence, predictors, and prognostic implications. Am Heart J (2008) 0.90
Effects of cardiac resynchronization therapy on left ventricular twist. J Am Coll Cardiol (2009) 0.89
New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association. Europace (2013) 0.88
Automatic management of left ventricular stimulation: hints for technologic improvement. Pacing Clin Electrophysiol (2009) 0.88
Atrial threshold variability: implications for automatic atrial stimulation algorithms. Pacing Clin Electrophysiol (2007) 0.88
EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. Eur Heart J Cardiovasc Imaging (2016) 0.88
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference. Thromb Haemost (2011) 0.87
Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project. Circ Cardiovasc Qual Outcomes (2012) 0.87
Atrial evoked response integral for automatic capture verification in atrial pacing. Pacing Clin Electrophysiol (2003) 0.86
Telecardiology and remote monitoring of implanted electrical devices: the potential for fresh clinical care perspectives. J Gen Intern Med (2008) 0.86
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: time courses and prediction of response. Peptides (2006) 0.86
Left ventricular rotational mechanics in acute myocardial infarction and in chronic (ischemic and nonischemic) heart failure patients. Am J Cardiol (2009) 0.86
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Vessels (2007) 0.85
Accelerated QRS widening as an independent predictor of cardiac death or of the need for heart transplantation in patients with congestive heart failure. J Heart Lung Transplant (2002) 0.85
Globalization of the epidemiologic, clinical, and financial burden of atrial fibrillation. Chest (2012) 0.85
Massive pulmonary embolism with acute coronary syndrome-like electrocardiogram mimicking acute left main coronary artery obstruction. J Emerg Med (2011) 0.85
The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias. Am Heart J (2008) 0.85
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction. Expert Rev Med Devices (2013) 0.84
Evaluation of the atrial evoked response for capture detection with high-polarization leads. Pacing Clin Electrophysiol (2005) 0.84
Atrial fibrillation therapy in patients with a CRT defibrillator with wireless telemetry. Pacing Clin Electrophysiol (2009) 0.84
Left ventricular versus biventricular pacing: a randomized comparative study evaluating mid-term electromechanical and clinical effects. Echocardiography (2008) 0.84
The EHRA White Book. Europace (2012) 0.84
Cost-effectiveness of cardiac resynchronisation therapy. Heart (2012) 0.84
Management of phrenic stimulation in CRT patients over the long term: still an unmet need ? Pacing Clin Electrophysiol (2011) 0.84